Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

115M Euro Grant for Precision Medicine, Trials in Autism

Autism graphic

A new initiative in Europe is investigating the connection between a person’s molecular composition and autism, particularly when other disorders complicate that individual’s condition. . . . → Read More: 115M Euro Grant for Precision Medicine, Trials in Autism

Connected Meters, Coaching Help Improve Diabetes Outcomes

Livongo meter

A study of people with type 2 diabetes shows the combination of intensive lifestyle coaching with a blood glucose meter connected to the Internet results in more weight loss and lower blood glucose levels. . . . → Read More: Connected Meters, Coaching Help Improve Diabetes Outcomes

Hospital Network Formed for Childhood Cancer Immunotherapies

T-cells illustration

A network of academic children’s medical centers is being formed to expand access to clinical trials testing immunotherapy treatments for childhood cancer. . . . → Read More: Hospital Network Formed for Childhood Cancer Immunotherapies

FDA Issues Guidance on Patient Experience Data Collection

Scott Gottlieb

The Food and Drug Administration issued draft regulatory guidance outlining methods for collecting data from patients that the agency says will help improve evaluations of more precisely targeted drugs. . . . → Read More: FDA Issues Guidance on Patient Experience Data Collection

Blood Tests Shown Able to Identify Early Lung Cancer

lung illustration

Results from a large-scale clinical trial show an analysis of blood samples can detect and identify the presence of characteristic DNA indicating a person may have early stages of lung cancer. . . . → Read More: Blood Tests Shown Able to Identify Early Lung Cancer

Stem Cell Transplants Found Safe for Spinal Cord Injuries

Spine model

Results from a clinical trial testing transplants of neural stem cells for spinal cord injuries show the therapies are safe for patients, with signs of improvement in most participants 1 to 2 years after treatment. . . . → Read More: Stem Cell Transplants Found Safe for Spinal Cord Injuries

FDA Delays Crispr Trial for Inherited Blood Diseases

Crispr-Cas9 illustration

The U.S. Food and Drug Administration put a hold on beginning a clinical trial of the emerging genome editing technique known as Crispr to treat inherited blood disorders. . . . → Read More: FDA Delays Crispr Trial for Inherited Blood Diseases

Immunotherapy Trial Shows Increased Brain Cancer Survival

Robert Fenstermaker and Michael Ciesielski

Results from a clinical trial show an experimental treatment for an aggressive form of brain cancer that harnesses the immune system extends patients’ survival, when combined with standard cancer care. . . . → Read More: Immunotherapy Trial Shows Increased Brain Cancer Survival

New ALS Drug Formula Shown Active, Safe

Neurons

A new formulation of a current drug to treat amyotrophic lateral sclerosis, or ALS, shows in its first clinical trial the drug produces more active ingredients against ALS than the current drug and causes no safety concerns. . . . → Read More: New ALS Drug Formula Shown Active, Safe

Long-Term Effects Shown from Hemophilia Gene Therapy

Drop of blood

Participants in a clinical trial testing a one-time genetic therapy to treat a rare form of hemophilia sharply reduced their bleeding incidents after a year, with few adverse effects, none considered serious. . . . → Read More: Long-Term Effects Shown from Hemophilia Gene Therapy